IDH1 and neoplasm: The identification of genetic markers stayed at the basis of the elaboration of the updated 2016 World Health Organisation (WHO) classification of tumors of the Central Nervous System (CNS), which for the first time integrated the status of the IDH gene and 1p/19q co-deletion into the diagnostic criteria [3].